DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR INLYTA

« Back to Dashboard

Clinical Trials for Inlyta

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00700258	Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]	Recruiting	Pfizer	N/A	The purpose of this registry is to obtain a general view as regards efficacy, tolerability and safety issues of the Torisel®, Sutent®, and/or Inlyta® therapies in patients with advanced renal cell carcinoma, recurrent / refractory mantle cell lymphoma (MCL) and gastro-intestinal stroma tumors (GIST) under the conditions of routine use
NCT01321437	Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma	Active, not recruiting	Pfizer	Phase 2	The purpose of this research study is to determine the efficacy of Axitinib in treating individuals with Stage III melanoma.
NCT01321437	Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma	Active, not recruiting	University of California, Irvine	Phase 2	The purpose of this research study is to determine the efficacy of Axitinib in treating individuals with Stage III melanoma.

Clinical Trial Conditions for Inlyta

Condition Name

Condition Name for Inlyta
Intervention	Trials
Clear Cell Renal Cell Carcinoma	4
Stage IIIB Melanoma	2
Advanced Renal Cell Carcinoma	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Inlyta
Intervention	Trials
Carcinoma, Renal Cell	14
Carcinoma	11
Melanoma	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Inlyta

Trials by Country

Trials by Country for Inlyta
Location	Trials
United States	130
Japan	10
Russian Federation	6
Korea, Republic of	5
Canada	5

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Inlyta
Location	Trials
California	8
New York	6
Ohio	6
Texas	6
Florida	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Inlyta

Clinical Trial Phase

Clinical Trial Phase for Inlyta
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	2
Phase 2	16

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Inlyta
Clinical Trial Phase	Trials
Recruiting	17
Not yet recruiting	7
Active, not recruiting	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Inlyta

Sponsor Name

Sponsor Name for Inlyta
Sponsor	Trials
Pfizer	11
National Cancer Institute (NCI)	3
Merck Sharp & Dohme Corp.	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Inlyta
Sponsor	Trials
Industry	22
Other	21
NIH	3

Export unavailable in trial.
Subscribe for complete access.